Compugen s Q1 Revenues Slide 43 Percent as R&D, Losses Swell | GenomeWeb

NEW YORK, April 20 (GenomeWeb News) - Compugen today reported an 43-percent drop in revenues and a rising net loss for the first quarter of 2005.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.